HS-20093 does not bind DNA topoisomerase; it binds B7-H3 and is internalized, then releases a topoisomerase inhibitor that kills B7-H3–positive cells via DNA replication blockade and apoptosis. Expression of DNA topoisomerase alone does not make cells a direct target.